Name: EBS Income Statement - Emergent Biosolutions Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

EBS - Emergent Biosolutions Inc.

USD | NYSE | Healthcare

EBS Income Statement - Emergent Biosolutions Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	156.1	148.7	231.1	140.9	222.2	194.7	293.8	254.7	300.4	276.6	270.5	337.9	164.3	330.2	239.9	242.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	676.8	742.9	1,043.6	1,049.3	1,117.5	1,773.6	1,577.3	1,106.0	782.4	560.9	488.8	522.8	450.1	312.7	281.9	273.4	286.2	234.8
Cost of Revenue	309.7	326.2	681.3	705.4	693.1	748.1	537.0	433.5	322.3	187.7	126.3	107.5	102.0	62.1	46.1	42.2	47.1	46.3
Gross Profit	367.1	416.7	362.3	343.9	424.4	1,025.5	1,040.3	672.5	460.1	373.2	362.5	415.3	348.2	250.6	235.8	231.2	239.1
Operating Expenses
Research & Development	48.6	53.2	70.7	111.4	188.3	235.2	237.9	226.2	142.8	97.4	106.9	119.2	104.7	119.9	120.2
Operating Income
Operating Income	60.7	100.1	(108.7)	(726.4)	(170.0)	341.4	438.5	114.1	89.8	124.3	105.5	141.5	89.2	42.8
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	1.8	1.1	0.6	0.3	0.1	0.1	0.1
Tax & Net
Income Tax Expense	12.1	30.2	47.7	29.3	(7.4)	83.7	106.1	22.9	18.8	36.0	36.7	44.3	29.9	13.1	13.9
Per Share
EPS Basic	(0.17)	0.98	(3.60)	(14.85)	(4.22)	4.10	5.80	1.06	1.25	1.98	1.29	1.63	0.98	0.86	0.65	0.65
Supplementary Data
EBITDA	154.6	195.9	0.1	(601.3)	(26.7)	465.2	488.6	163.6	126.1	156.5	133.5	165.3	111.5	59.8	41.2	41.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	10.5	12.1	13.5	12.5	15.1	9.1	13.8	32.7	15.1	29.4	15.3	26.0	40.7	49.9	42.2	49.8	46.4	84.2	49.6	48.9	52.5	62.9	84.4	47.9	42.7	62.8	53.4	63.9	46.1	52.0	37.0	24.7	29.1	28.5	22.7	25.8	20.5	25.7	27.2	27.9
Selling General & Administrative	46.6	51.1	38.9	43.7	52.4	60.8	76.6	85.9	84.7	89.7	86.0	91.4	101.3	91.8	81.8	81.1
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	23.5	56.0	7.1	7.3	25.4	58.6	10.1	12.2	27.9	62.0	11.7	16.8	34.6	63.6	20.3	28.5
Amortization of Intangibles	16.5	16.3	16.3	16.2	16.3	16.3	16.3	16.3	16.2	16.2	16.3	16.1	17.0	17.9	14.0	14.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	10.5	(27.9)	76.5	1.6	49.9	(9.5)	64.5	(203.5)	39.8	(43.8)	(242.1)	(292.9)	(147.6)	(55.3)	(45.3)	(76.3)	6.9	266.2	(34.7)	14.5	95.4	262.8	61.3	126.0	(11.6)	77.6	70.7	(7.0)	(27.2)	11.2	21.3	66.8	(9.5)	53.1	47.8	8.5	14.9	50.9	35.5	(2.0)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.7	0.3	0.2	0.2	0.6	0.6	0.4	0.3	0.4	0.2
Interest Expense	11.0	14.7	15.2	14.7	14.7	14.8	8.3	23.6	24.3	21.7	19.7	28.6	17.9	12.8	8.5	7.8	8.2	9.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	2.9	(22.8)	(18.9)	(18.4)	42.8	(18.1)	77.9	(66.3)	(27.7)	(10.7)	(23.8)	42.7	(13.0)	(6.1)	(21.9)	(10.8)	(10.2)
Pre-Tax Income	13.4	(50.7)	57.6	(16.8)	92.7	(27.6)	142.4	(269.8)	12.1	(54.5)	(265.9)	(250.2)	(160.6)	(65.2)	(67.2)	(82.8)

Tax & Net
Income Tax Expense	6.6	3.9	6.4	(4.8)	24.7	3.7	27.6	13.3	3.1	(5.0)	(2.5)	11.2	25.6	(0.8)	19.9	(26.4)	(0.1)	78.4	(12.8)	2.6	15.5	71.4	15.5	28.0	(8.8)	24.6	15.7	(5.6)	(11.8)	7.0	0.6	15.7	(4.5)	18.0	12.8	2.1	3.2	16.8	13.2	(1.3)
Net Income From Continuing Ops	6.8	(54.6)	51.2	(12.0)	68.0	(31.3)	114.8	(283.1)	9.0	(49.5)	(263.4)	(261.4)	(186.2)	(67.0)	(87.1)	(52.9)	(4.6)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	6.8	(54.6)	51.2	(12.0)	68.0	(31.3)	114.8	(283.1)	9.0	(49.5)	(263.4)	(261.4)	(186.2)	(67.0)	(87.1)	(52.9)	(4.6)
Net Income Attributable To Parent	6.8	(54.6)	51.2	(12.0)	68.0	(31.3)	114.8	(283.1)	9.0	(49.5)	(263.4)	(261.4)	(186.2)	(67.0)	(87.1)	(52.9)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	6.8	(54.6)	51.2	(12.0)	68.0	(31.3)	114.8	(283.1)	9.0	(49.5)	(263.4)	(261.4)	(186.2)	(67.0)	(87.1)

Per Share
EPS Basic	0.13	-	0.96	(0.22)	1.25	-	2.16	(5.38)	0.17	-	(5.08)	(5.16)	(3.71)	-	(1.75)	(1.06)	(0.09)	-	(0.61)	0.09	1.31	-	0.75	1.76	(0.24)	-	0.84	(0.18)	(0.51)	-	0.42	1.00	(0.10)	-	0.81	0.11	0.26	-	0.52	(0.27)
EPS Diluted	0.07	-	0.91	(0.22)	1.19	-	2.06	(5.38)	0.17	-	(5.08)	(5.16)	(3.71)	-	(1.75)	(1.06)	(0.09)	-
Shares Basic	51.9	-	53.2	54.2	54.4	-	53.1	52.6	52.2	-	51.8	50.7	50.2	-	49.9	50.0	50.7	-
Shares Diluted	56.5	-	56.5	54.2	57.3	-	55.6	52.6	52.2	-	51.8	50.7	50.2	-	49.9	50.0	50.7	-

Supplementary Data
EBITDA	34.0	28.1	83.6	8.9	75.3	49.1	74.6	(191.3)	67.7	18.2	(230.4)	(276.1)	(113.0)	8.3	(25.0)	(47.8)	37.8	328.4	(20.3)	33.0	124.1	-	-	-	16.6	-	-	-	(0.6)	-	-	-	2.8	-	-	-	25.1	-	-	-
EBIT	10.5	(27.9)	76.5	1.6	49.9	(9.5)	64.5	(203.5)	39.8	(43.8)	(242.1)	(292.9)	(147.6)	(55.3)	(45.3)	(76.3)	6.9	266.2	(34.7)